Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more about TLRY stock here.
The 5-minute investor podcast, ep. 65: Cannabis stocks cultivating alpha
Welcome to episode 65 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute profile on a stock related to recent investment news.
The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here’s What That Means for Every Cannabis Investor.
Last week, Trulieve Cannabis (OTC: TCNNF) (NYSE:TRLV) became the first U.S. cannabis operator to list on the New York Stock Exchange. The stock is now trading under the symbol “TR …
Aurora Cannabis Q4 Earnings Call Highlights
Aurora Cannabis (NASDAQ:ACB) reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as …
This US Cannabis Giant Is Launching Its First Premium Offering In Germany – Why It Matters?
Tilray’s ARX brand will be launched at the world’s largest cannabis expo and festival, Mary Jane Berlin 2026, which kicks off in two days.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
CRON strengthens global footprint: Is the cannabis stock worth buying?
Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and executes on several strategic initiatives. The company has been expanding its …
Trulieve’s NYSE listing is historic. But is the stock still worth buying?
The listing matters, but fundamentals matter more.
Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec”
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings. A caller …
Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more about TLRY stock here.
Cannabis Has Dozens Of Public Companies. Wall Street Acts Like It Has Seven.
Cannabis stocks have rallied 104% in a year, but only seven North American operators clear the institutional threshold that matters to Wall Street.
Why Are Cannabis Stocks Gaining Attention Right Now
Cannabis companies attract renewed attention as reclassification discussions progress and upcoming regulatory proceedings shape expectations across the evolving industry.
Robinhood Is Opening the Door to U.S. Cannabis With Reform On the Horizon
Trulieve, Curaleaf, and Green Thumb Industries showed up on the app this week as the federal government inches toward reclassifying recreational marijuana.
Cannabis, Wellness And Beverages: Three Names To Watch
Tilray, Canopy Growth and Cronos are three US-listed names at the intersection of cannabis, wellness and beverages.
Cannabis Stocks On NASDAQ Markets: A Guide For U.S.
Discover how U.S.-traded cannabis stocks work, what defines the cannabis universe on NASDAQ and OTC markets, and what U.S. investors typically consider.
Recent Comments